On Monday 14 January as part of the Qatar Tour, the Paris Saint-Germain players participated in numerous activities organised by the club’s and its Qatari partners.
The Qatar National Tourism Council (QNTC) took Neymar Jr., Gianluigi Buffon, Angel Di Maria and Thiago Silva on a trip to the heart of the desert to film an advertisement on athletes’ performance, intensity and perseverance.
Alphonse Aréola, Thilo Kehrer, Presnel Kimpembe, Thomas Meunier and Christopher Nkunku, were among the first passengers to ride the soon-to-open metro line to Al Wakrah Stadium, and enjoyed an exclusive tour of the arena currently under construction for the 2022 FIFA World Cup.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8481251-paris-saint-germain-football-qatar-tour/
The 11th annual Amgen Tour of California presented by AEG entered its second decade as America's most prestigious annual cycling event, welcoming an unsurpassed field of professional teams for the race start in San Diego. One of the most important races on the international calendar, the 8'day event attracts some of the brightest cycling stars in the world to the golden state each May. This year’s field features 11 World Champions, five Olympic medalists and Rio Olympic hopefuls, with more than 30 countries represented.
The 2016 Amgen Tour of California includes 10 UCI WorldTour Teams, the most in race history, as some of the top cyclists in the world face off across nearly 800 miles of California terrain May 15-22, visiting 12 Host Cities from San Diego to Sacramento.
2016 marks the debut of the UCI Women's WorldTour, which brings the highest level of professional women's cycling competition to cities around the world. The four-day Amgen Breakaway from Heart Disease Women's Race Empowered with SRAM May 19-22 marks the U.S. debut of the Women’s WorldTour and will showcase some of the best talent in the sport. The peloton will include two-time Olympic champion Kristin Armstrong and eight Rio Olympic hopefuls.
The eight-stage men’s event began Sunday with 18 of the world’s most decorated and esteemed teams competing for one of the sport’s most coveted titles. World Champion and reigning race champion Peter Sagan of Tinkoff roared to victory in a bunch sprint to the finish line in Mission Beach, San Diego, putting him back into the yellow leader jersey he wore at the race’s conclusion last year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7831951-amgen-tour-of-california/
The Great Depression was a time of sacrifice, and sixteen-year-old Sooze Williams chooses to sacrifice her heart and her future to help her family and save her brother. A murder, a betrayal, a trial. If you like Steinbeck and Grisham you will want to read Shadow of the Hawk by K.S. Jones. Find out more at http://ksjones.com. #ShadowoftheHawk Thriller/Literary/YA
No matter how fast you run, your can’t outrun your past. Cat Benoit escaped the man who would claim her as his own, a man who showed her something terrifying awaited her. She re-made her life, hidden away. But a new threat, one of the heart, one that called to her in a way she’d never imagined, came to help her, claim her.
Two men would do anything to keep her. And as Cat fights to own herself, she finds another world open to her. A world of leopards and men who become them. Find out more at http://www.ChristineFeehan.com Paranormal romance
Noted pediatric heart surgeon Dr. Kristine Guleserian has opened up her OR, and her career to author Mark Oristano to create Surgeon’s Story Inside OR 6 With a top Pediatric Heart Surgeon. Dr. Guleserian’s life, training and work are discussed in detail, framed around the incredibly dramatic story of a heart transplant operation for a two-year old girl whose own heart was rapidly dying. Find out more at- http://surgeonsstory.com/ Media Contact: For a review copy of Surgeon’s Story or to schedule an interviewwith Mark Oristano, contact Scott Lorenz of Westwind Communications Book Marketing, 734 667 2090 scottlorenz@westwindcos.com or http://www.book-marketing-expert.com Medical Non-Fiction
Ranked a hot city for business, a top-20 college town and listed as one of the friendliest places in America by Travel & Leisure magazine, Knoxville, Tennessee, is the location of HGTV Urban Oasis® 2017. Fans can now take a virtual tour of the renovated 1925 bungalow and then enter for a chance to win the fully furnished home during the upcoming sweepstakes period.
Located in the historic Fourth and Gill neighborhood close to vibrant downtown Knoxville and the University of Tennessee campus, the charming home features an all-new interior and enhanced exterior with eye-catching design touches and aptly lends itself to sustainable urban living in one of Knoxville’s hottest neighborhoods. Fourth and Gill was chosen for HGTV Urban Oasis 2017 due to its unique vibe and proximity to the heart of downtown, which features a plethora of restaurants, bars, outdoor concerts, shopping and other year-round activities.
“With our corporate headquarters right here in Knoxville, we know what an up-and-coming metropolis our city truly is – it has it all, including an urban feel infused with Southern hospitality,” said Ron Feinbaum, General Manager of HGTV Home Promotions. “Our team is accustomed to traveling the country to produce the top-notch homes we give away to our viewers each year. With this project, it’s particularly gratifying to be able to showcase all that our ‘Scruffy City’ has to offer – from an exploding culinary scene to endless outdoor adventure.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8041053-hgtv-urban-oasis-2017-knoxville-tennessee/
It is 1973, and Paris still simmers from the 1968 civil unrest. But Monica, a naïve American college student, disregards the dangerous events taking place, and risks her heart––and her safety–– as she unwittingly becomes embroiled with a terrorist intent on using her as a pawn in a scheme of political destruction. Find out more at http://www.ceciliavelastegui.com/ Parisian Promises by Cecilia Velastegui. Thriller
Dr. Maurice Rawlings, MD, a heart surgeon, has written a number of books on the near-death experience and clearly shows from his own practice and the experiences of his patients, that not everyone goes to the light when they die, where there is total love. He has written of many patients being resuscitated on the operating table and speaking about being in hell, where there was a real devil and demons, and where the inhabitants were tormented with fire. Dr. Rawlings writes that these people are a lot more reluctant to talk about it than those who went to the good place. DivineRevelations.info
Many women don't realize aging makes heart disease likelier. To combat this problem, teams from Brookdale senior living communities nationwide are fanning out to personally alert women 65 and over to their increased risk and provide resources to fight it. The company hopes to reach 10,000 older women through “10,000 Heart to Hearts,” beginning Feb. 1.
“Cardiac disease kills more women than all cancers combined,” said Brookdale chief medical officer Kevin O'Neil, M.D., F.A.C.P. “On average, women develop heart disease 10 years later than men, with their first heart attack occurring at age 70.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7087732-brookdale-senior-living/
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
From bagels to sushi, the internet has been abuzz with the outrageous Cheetos-infused recipes going viral and popping up at restaurants around the country. Cheetos, one of the flagship brands from PepsiCo’s Frito-Lay division, is now bringing Cheetos-inspired dishes to life in New York City at The Spotted Cheetah, the first-ever restaurant devoted to all things Cheetos.
Located in the heart of New York City at 211 W. Broadway, The Spotted Cheetah will be open to the public by reservation only August 15 – August 17 and will provide guests the opportunity to enjoy the ultimate Cheetos dining experience. The menu combines the beloved cheese and crunch of Cheetos with chef Anne Burrell’s culinary talent. With her trademark spiky blonde hair and fun, pumped-up personality, Burrell has worked some of the top restaurants in New York, including her new restaurant, Phil & Anne's Good Time Lounge, studied culinary landscape and traditions of Italy, and authored two popular cookbooks, Cook Like A Rockstar and Own Your Kitchen. Now she's lending her culinary expertise at something completely different with the world's first Cheetos restaurant.
To view the multimedia release go to:
https://www.multivu.com/players/English/8152751-frito-lay-cheetos-restaurant-the-spotted-cheetah/
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
